Search results

Technologies 2

• Brain Targeting Program: Shuttles for Brain Delivery of Therapeutics and Diagnostics
  In its Brain Targeting Program, a Wyss team led by Founding Director Donald Ingber, M.D., Ph.D. and Staff Program Lead James Gorman, M.D., Ph.D. is developing improved approaches to target drugs and diagnostics to the brain. Leveraging the human blood-brain barrier (BBB) Chip technology developed by Ingber’s team, combined with advanced antibody R&D capabilities, the...
• Engineered Brain Organoids
  The ability to derive and manipulate pluripotent stem cells has opened up new avenues for modeling biological systems in both healthy and diseased conditions. In order to more fully recapitulate the tissue microenvironment with its cell-cell, cell-extracellular matrix, and cell-niche interactions, it is essential to transition stem-cell culturing from monolayers to 3D structures. Self-organization of...

News 5

View all

• Press Release
  
  Enhanced human Blood-Brain Barrier Chip performs in vivo-like drug and antibody transport
  June 13, 2019
• Awards
  
  David Walt and George Church receive grant from Chan Zuckerberg Initiative to enable better diagnosis and monitoring of Parkinson’s disease
  December 5, 2018
• Press Release
  
  Taking the brain apart to put it all together again
  August 20, 2018